GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) » Definitions » Gross Profit

MicroTech Medical (Hangzhou) Co (HKSE:02235) Gross Profit : HK$134.8 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is MicroTech Medical (Hangzhou) Co Gross Profit?

MicroTech Medical (Hangzhou) Co's gross profit for the six months ended in Dec. 2023 was HK$71.8 Mil. MicroTech Medical (Hangzhou) Co's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was HK$134.8 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. MicroTech Medical (Hangzhou) Co's gross profit for the six months ended in Dec. 2023 was HK$71.8 Mil. MicroTech Medical (Hangzhou) Co's Revenue for the six months ended in Dec. 2023 was HK$150.4 Mil. Therefore, MicroTech Medical (Hangzhou) Co's Gross Margin % for the quarter that ended in Dec. 2023 was 47.70%.

MicroTech Medical (Hangzhou) Co had a gross margin of 47.70% for the quarter that ended in Dec. 2023 => Durable competitive advantage

During the past 5 years, the highest Gross Margin % of MicroTech Medical (Hangzhou) Co was 49.62%. The lowest was 46.37%. And the median was 46.82%.


MicroTech Medical (Hangzhou) Co Gross Profit Historical Data

The historical data trend for MicroTech Medical (Hangzhou) Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroTech Medical (Hangzhou) Co Gross Profit Chart

MicroTech Medical (Hangzhou) Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
26.80 43.32 86.79 87.97 134.78

MicroTech Medical (Hangzhou) Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Profit Get a 7-Day Free Trial 48.22 37.25 52.49 63.02 71.76

Competitive Comparison of MicroTech Medical (Hangzhou) Co's Gross Profit

For the Medical Devices subindustry, MicroTech Medical (Hangzhou) Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MicroTech Medical (Hangzhou) Co's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroTech Medical (Hangzhou) Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where MicroTech Medical (Hangzhou) Co's Gross Profit falls into.



MicroTech Medical (Hangzhou) Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

MicroTech Medical (Hangzhou) Co's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=271.636 - 136.859
=134.8

MicroTech Medical (Hangzhou) Co's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )=Revenue - Cost of Goods Sold
=150.43 - 78.67
=71.8

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$134.8 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

MicroTech Medical (Hangzhou) Co's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=71.8 / 150.43
=47.70 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


MicroTech Medical (Hangzhou) Co  (HKSE:02235) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

MicroTech Medical (Hangzhou) Co had a gross margin of 47.70% for the quarter that ended in Dec. 2023 => Durable competitive advantage


MicroTech Medical (Hangzhou) Co Gross Profit Related Terms

Thank you for viewing the detailed overview of MicroTech Medical (Hangzhou) Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


MicroTech Medical (Hangzhou) Co (HKSE:02235) Business Description

Traded in Other Exchanges
N/A
Address
No. 108 Liuze Street, Cangqian Street, Yuhang District, Zhejiang Province, Hangzhou, CHN
MicroTech Medical (Hangzhou) Co Ltd is engaged in the research and development and manufacturing and commercialization of diabetes management, providing both diabetes treatment and diabetes monitoring medical devices to improve diabetes management in China and the rest of the world. The company derives a majority of its revenue from China.
Executives
Zheng Pan
Master Summer Limited 2201 Interest of corporation controlled by you
Cdbi Partners Gp, Ltd 2201 Interest of corporation controlled by you
Cdbi Partners Fund Ii, L.p. 2201 Interest of corporation controlled by you
Cdbi Partners Fund I, L.p. 2201 Interest of corporation controlled by you
Cdbi Gp, Ltd 2201 Interest of corporation controlled by you
Cd Capital Healthcare Fund V, L.p. 2201 Interest of corporation controlled by you
Cd Capital Gp Ltd 2201 Interest of corporation controlled by you
Zhe Jiang Jiu Ren Zi Ben Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Qiming Corporate Gp V, Ltd. 2201 Interest of corporation controlled by you
Qiming Gp V, L.p. 2201 Interest of corporation controlled by you
Qiming Venture Partners V, L.p. 2201 Interest of corporation controlled by you
Qm32 Limited 2101 Beneficial owner
Lav Asset Management (hong Kong) Limited 2102 Investment manager
Lav Evergreen (hong Kong) Co., Limited 2101 Beneficial owner

MicroTech Medical (Hangzhou) Co (HKSE:02235) Headlines

No Headlines